Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 193Carcinoma, Non-Small-Cell Lung 160Ovarian Neoplasms 96Lung Neoplasms 58Fallopian Tube Neoplasms 57Neoplasms 50Triple Negative Breast Neoplasms 36Neoplasm Metastasis 36Esophageal Neoplasms 22Carcinoma, Ovarian Epithelial 22Parkinson Disease 4, Autosomal Dominant Lewy Body 21Stomach Neoplasms 20Squamous Cell Carcinoma of Head and Neck 20Head and Neck Neoplasms 19Endometrial Neoplasms 19Adenocarcinoma of Lung 17Melanoma 15Breast Neoplasms, Male 15Urinary Bladder Neoplasms 13Carcinoma 12Uterine Cervical Neoplasms 11Recurrence 11Carcinoma, Squamous Cell 11Brenner Tumor 11Adenocarcinoma Of Esophagus 10Small Cell Lung Carcinoma 9Peritoneal Neoplasms 9Esophageal Squamous Cell Carcinoma 9Adenocarcinoma, Bronchiolo-Alveolar 9Prostatic Neoplasms 8

Interventions

Radiotherapy 3Carboplatin 3Trastuzumab 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2proto-oncogene protein c-fes-fps 1palbociclib 1gallium 68 PSMA-11 1fluciclovine F-18 1Vorinostat 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Radiation 1Paclitaxel 1Naltrexone 1Melphalan 1Letrozole 1Fulvestrant 1Fluorine-18 1Drugs, Generic 1Doxorubicin 1Docetaxel 1Crizotinib 1Counseling 1Chemotherapy, Adjuvant 1Albumin-Bound Paclitaxel 168Ga-DKFZ-PSMA-11 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Lobular × Paclitaxel × Clear all
NCT00295893 2025-09-25

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
121 enrolled 10 charts
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡